Zangemeister-Wittke U - Search Results

1

Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.

Aguirre D, Boya P, Bellet D, Faivre S, Troalen F, Benard J, Saulnier P, Hopkins-Donaldson S, Zangemeister-Wittke U, Kroemer G, Raymond E. Aguirre D, et al. Apoptosis. 2004 Nov;9(6):797-805. doi: 10.1023/B:APPT.0000045781.46314.e2. Apoptosis. 2004. PMID: 15505422

2

Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment.

Hopkins-Donaldson S, Cathomas R, Simões-Wüst AP, Kurtz S, Belyanskaya L, Stahel RA, Zangemeister-Wittke U. Hopkins-Donaldson S, et al. Int J Cancer. 2003 Aug 20;106(2):160-6. doi: 10.1002/ijc.11209. Int J Cancer. 2003. PMID: 12800189

3

A functionally improved locked nucleic acid antisense oligonucleotide inhibits Bcl-2 and Bcl-xL expression and facilitates tumor cell apoptosis.

Simões-Wüst AP, Hopkins-Donaldson S, Sigrist B, Belyanskaya L, Stahel RA, Zangemeister-Wittke U. Simões-Wüst AP, et al. Oligonucleotides. 2004;14(3):199-209. doi: 10.1089/oli.2004.14.199. Oligonucleotides. 2004. PMID: 15625915

4

Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.

Hopkins-Donaldson S, Ziegler A, Kurtz S, Bigosch C, Kandioler D, Ludwig C, Zangemeister-Wittke U, Stahel R. Hopkins-Donaldson S, et al. Cell Death Differ. 2003 Mar;10(3):356-64. doi: 10.1038/sj.cdd.4401157. Cell Death Differ. 2003. PMID: 12700635

5

DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.

Simões-Wüst AP, Sigrist B, Belyanskaya L, Hopkins Donaldson S, Stahel RA, Zangemeister-Wittke U. Simões-Wüst AP, et al. J Neurooncol. 2005 Mar;72(1):29-34. doi: 10.1007/s11060-004-3118-8. J Neurooncol. 2005. PMID: 15803372

6

TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.

Belyanskaya LL, Ziogas A, Hopkins-Donaldson S, Kurtz S, Simon HU, Stahel R, Zangemeister-Wittke U. Belyanskaya LL, et al. Lung Cancer. 2008 Jun;60(3):355-65. doi: 10.1016/j.lungcan.2007.11.005. Epub 2008 Feb 21. Lung Cancer. 2008. PMID: 18093694

7

Apoptosis regulation and drug resistance in malignant pleural mesothelioma.

Zangemeister-Wittke U, Hopkins-Donaldson S. Zangemeister-Wittke U, et al. Lung Cancer. 2005 Jul;49 Suppl 1:S105-8. doi: 10.1016/j.lungcan.2005.03.019. Lung Cancer. 2005. PMID: 15888351 No abstract available.

8

Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation.

Belyanskaya LL, Hopkins-Donaldson S, Kurtz S, Simões-Wüst AP, Yousefi S, Simon HU, Stahel R, Zangemeister-Wittke U. Belyanskaya LL, et al. Int J Cancer. 2005 Dec 10;117(5):755-63. doi: 10.1002/ijc.21242. Int J Cancer. 2005. PMID: 15981204

9

p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.

Hopkins-Donaldson S, Belyanskaya LL, Simões-Wüst AP, Sigrist B, Kurtz S, Zangemeister-Wittke U, Stahel R. Hopkins-Donaldson S, et al. Neoplasia. 2006 Jul;8(7):551-9. doi: 10.1593/neo.06148. Neoplasia. 2006. PMID: 16867217 Free PMC article.

10

p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide.

Strasberg Rieber M, Zangemeister-Wittke U, Rieber M. Strasberg Rieber M, et al. Clin Cancer Res. 2001 May;7(5):1446-51. Clin Cancer Res. 2001. PMID: 11350916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters